Congeneric Lantibiotics from Ribosomal In Vivo Peptide Synthesis with Noncanonical Amino Acids
- 30 November 2011
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 51 (2) , 415-418
Abstract
Expanded repetoire: Synthetic amino acids translated into propeptides dramatically increase the chemical diversity of the two-component lantibiotic lichenicidin. This opens new routes towards novel and unique peptide antibiotic sequences, which could display features important for medical applications.Keywords
This publication has 29 references indexed in Scilit:
- Solid Supported Chemical Syntheses of Both Components of the Lantibiotic Lacticin 3147Journal of the American Chemical Society, 2011
- Evolution of cyclic peptide protease inhibitorsProceedings of the National Academy of Sciences, 2011
- Heterologous Expression, Biosynthesis, and Mutagenesis of Type II Lantibiotics from Bacillus licheniformis in Escherichia coliChemistry & Biology, 2011
- Production of Lantipeptides in Escherichia coliJournal of the American Chemical Society, 2010
- Labyrinthopeptine – eine neue Klasse carbacyclischer LantibiotikaAngewandte Chemie, 2010
- Analysis and Optimization of Copper‐Catalyzed Azide–Alkyne Cycloaddition for BioconjugationAngewandte Chemie, 2009
- Analysis and Optimization of Copper‐Catalyzed Azide–Alkyne Cycloaddition for BioconjugationAngewandte Chemie International Edition, 2009
- Identification of a Novel Two-Peptide Lantibiotic, Lichenicidin, following Rational Genome Mining for LanM ProteinsApplied and Environmental Microbiology, 2009
- Biosynthesis and Mode of Action of LantibioticsChemical Reviews, 2005
- LANTIBIOTICS: Biosynthesis and Biological Activities of Uniquely Modified Peptides from Gram-Positive BacteriaAnnual Review of Microbiology, 1998